Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 10.43 Delayed Data As of Oct 22 |  -0.21 / -1.97%Today’s Change | 7.21 Today|||52-Week Range 16.37 | -17.22% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Decheng Capital Llc Director |  Buy | 9/17/2021 | 1,542,553 | $9.40 | $14.5M | +5.50% |
Decheng Capital Llc | Buy | 9/17/2021 | 1,542,553 | $9.40 | $14.5M | +5.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 585,106 | $9.40 | $5.5M | +5.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 585,106 | $9.40 | $5.5M | +5.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 425,531 | $9.40 | $4.0M | +5.50% |
Orbimed Advisors Private Equity Director | Buy | 9/17/2021 | 425,531 | $9.40 | $4.0M | +5.50% |
Alpine Bioventures Gp Llc Director |  Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | +5.50% |
Alpine Bioventures Gp Llc Executive Chairman & Chief Investment Officer | Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | +5.50% |
Alpine Bioventures Gp Llc | Sale | 9/17/2021 | 400,000 | $9.40 | $3.8M | +5.50% |
Gold Mitchell H Executive Chairman & Chief Investment Officer | Sale | 9/17/2021 | 45,262 | $10.01 | $453.1K | +5.50% |
Page of 4